Perioperative trastuzumab, capecitabine and oxaliplatin in patients with HER2-positive resectable gastric or gastro-oesophageal junction adenocarcinoma
Adding Herceptin to chemotherapy improved outcomes for patients with HER2-positive advanced gastric cancer in a clinical trial.
Chatter Between Cell Populations Drives Progression of Gastrointestinal Tumors
Researchers at UCSD discovered that cancer-associated fibroblasts within gastrointestinal stromal tumors (GISTs) communicate with GIST cells to drive tumor growth.
Early Interdisciplinary Supportive Care in Patients With Previously Untreated Metastatic Esophagogastric Cancer
Integrating interdisciplinary supportive care into the treatment of metastatic gastric cancer enhances survival benefits, a recent study published in the Journal of... Read More
Dynamic, personalized treatment approach may improve outcomes in gastroesophageal cancers
A University of Chicago study found that when treatments are customized for gastric cancer patients based on the genetic characteristics of their... Read More
The Gut Microbiome Offers Clues to Immunotherapy Efficacy in Advanced Gastric Cancer
Japanese researchers found a link between the gut microbiome and a positive response to the immunotherapy drug Opdivo in patients with gastric... Read More
Bemarituzumab Improves Gastric Cancer Survival Response Rates
In a study presented at ASCO GI, adding Five Prime’s experimental targeted drug to a modified FOLFOX chemotherapy regimen significantly improved survival... Read More
Single-cell analysis of metastatic gastric cancer finds diverse tumor cell populations associated with patient outcomes
MD Anderson researchers identified two subtypes of peritoneal carcinomatosis, a form of gastric cancer, and developed gene expression signatures that can be... Read More
Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis
A study found that “cytoreductive” surgery combined with intraperitoneal chemotherapy improved survival for some gastric cancer patients but that the strategy should... Read More
Immunotherapy May Work Better Against Stomach Cancer When Combined with Chemo, Given Earlier
Immunotherapy for stomach cancer may work better if the therapy is delivered earlier in the course of disease and in combination with... Read More
Foundation Funds Major Expansion of Gastric Cancer Registry
The Gastric Cancer Foundation has committed $257,856 to fund a transformative expansion of the Gastric Cancer Registry in 2021. The funding will... Read More
